23: Adjusted Inference for Multiple Testing Procedure in Group-Sequential Designs
Qi Liu
First Author
Merck & Co., Inc.
Qi Liu
Presenting Author
Merck & Co., Inc.
Monday, Aug 4: 10:30 AM - 12:20 PM
1414
Contributed Posters
Music City Center
In confirmatory clinical trials that employ multiple testing procedures, rigorous statistical inference is paramount to ensure validity. Two primary approaches exist to control for multiplicity: the first adjusts the significance levels and compares the unadjusted p-values against their corresponding adjusted thresholds, while the second adjusts p-values directly and evaluates them against the prespecified family-wise error rate (FWER). Implementing these methods in group-sequential designs, however, presents unique challenges. This work illustrates their application through examples of Weighted Bonferroni Group Sequential Design (WBGSD) and Weighted Parametric Group Sequential Design (WPGSD), highlighting practical considerations and interpretation.
clinical trial
multiplicity
statistical Inference
group sequential design
adjusted p-value
weighted parametric test
Main Sponsor
Biopharmaceutical Section
You have unsaved changes.